Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Swapneel Anaokar"'
Autor:
Dirk Kuypers, MD, PhD, Laurent Weekers, MD, PHD, Martin Blogg, BSc, CStat, Swapneel Anaokar, MD, Carola del Pilar Repetur, MSc, Vicky De Meyer, MD, Nada Kanaan, MD
Publikováno v:
Transplantation Direct, Vol 9, Iss 4, p e1465 (2023)
Background. Prolonged-release tacrolimus (PRT) may offer improved outcomes after kidney transplantation compared with immediate-release tacrolimus (IRT). However, data on outcomes beyond 5-y posttransplantation are lacking. Methods. A retrospective,
Externí odkaz:
https://doaj.org/article/39de8b50f9a645b9ba31a6e9f6454780
Autor:
Vincent Pernin, MD, PhD, Maciej Glyda, MD, PhD, Ondrej Viklický, MD, PhD, Aleksander Lõhmus, MD, Lars Wennberg, MD, PhD, Oliver Witzke, MD, Bengt von Zur-Mühlen, MD, PhD, Swapneel Anaokar, MD, Martin Hurst, FRCP(UK), Gbenga Kazeem, PhD, Nasrullah Undre, PhD, Dirk R.J. Kuypers, MD, PhD
Publikováno v:
Transplantation Direct, Vol 9, Iss 3, p e1432 (2023)
Background. Although prolonged-release tacrolimus (PR-T) is widely approved for posttransplantation immunosuppression in kidney recipients, large-scale studies are required to assess long-term outcomes. We present follow-up data from the Advagraf-bas
Externí odkaz:
https://doaj.org/article/041008a8494a460aa80436d2952ec7ba
Autor:
Styrbjörn Friman, MD, PhD, Giuseppe Tisone, MD, Frederik Nevens, MD, PhD, Frank Lehner, MD, Walter Santaniello, MD, Wolf O. Bechstein, MD, PhD, Sergey V. Zhuvarel, MD, Helena Isoniemi, MD, PhD, Oleg O. Rummo, MD, Jürgen Klempnauer, MD, Swapneel Anaokar, MBBS, MD, Martin Hurst, MBBS, FRCP, Gbenga Kazeem, PhD, Nasrullah Undre, PhD, Pavel Trunečka, MD, PhD
Publikováno v:
Transplantation Direct, Vol 7, Iss 8, p e722 (2021)
Background. Immunosuppression with calcineurin inhibitors (CNIs) is reportedly associated with risk of renal impairment in liver transplant recipients. It is believed that this can be mitigated by decreasing initial exposure to CNIs or delaying CNI i
Externí odkaz:
https://doaj.org/article/03070658369a4d6a8b22fd3cb723f616
Autor:
Dirk Kuypers, Laurent Weekers, Martin Blogg, Swapneel Anaokar, Carola del Pilar Repetur, Vicky De Meyer, Nada Kanaan
UNLABELLED: Prolonged-release tacrolimus (PRT) may offer improved outcomes after kidney transplantation compared with immediate-release tacrolimus (IRT). However, data on outcomes beyond 5-y posttransplantation are lacking. METHODS: A retrospective,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab723e57e931a6f03448722611500fd6
https://biblio.vub.ac.be/vubir/(2ab19480-c7bd-4521-8a4f-d5180bb4d909).html
https://biblio.vub.ac.be/vubir/(2ab19480-c7bd-4521-8a4f-d5180bb4d909).html
Autor:
Imran Hussain, Ian Dawson, Gbenga Kazeem, Nassim Kamar, Nicholas Torpey, Swapneel Anaokar, Varuna Aluvihare, Nasrullah Undre, Faouzi Saliba
Publikováno v:
Therapeutic Drug Monitoring
Background Tacrolimus is a narrow therapeutic index medication, which requires therapeutic drug monitoring to optimize dosing based on systemic exposure. MITRA microsampling offers a convenient, minimally invasive approach for the collection of capil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64af08011d758d1b2ab01baaa5cefc8c
http://europepmc.org/articles/PMC8115740
http://europepmc.org/articles/PMC8115740
Autor:
Antoine Durrbach, Jürgen Klempnauer, Maarten H. L. Christiaans, Frank Lehner, Nasrullah Undre, Mario Carmellini, Flavia Caputo, Dirk Kuypers, Martin Hurst, Christiane Mousson, Swapneel Anaokar, Gbenga Kazeem, Oleg O. Rummo, Nassim Kamar, Zoltan Mathe
Publikováno v:
Transplant International, 33(2), 161-173. Wiley
The objectives of this study were to assess long-term graft survival, patient survival, renal function, and acute rejections in de novo kidney transplant recipients, treated with once-daily prolonged-release tacrolimus-based therapy. The study was a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23dc17312e1acd21c86899493a550959
https://doi.org/10.1111/tri.13527
https://doi.org/10.1111/tri.13527
Autor:
Sergey V. Zhuvarel, Styrbjörn Friman, Gbenga Kazeem, Wolf O. Bechstein, W. Santaniello, Pavel Trunecka, Helena Isoniemi, Jürgen Klempnauer, Martin Hurst, Giuseppe Tisone, Frank Lehner, Oleg O. Rummo, Swapneel Anaokar, Nasrullah Undre, Frederik Nevens
Publikováno v:
Transplant Direct
Transplantation Direct
Transplantation Direct, Vol 7, Iss 8, p e722 (2021)
Transplantation Direct
Transplantation Direct, Vol 7, Iss 8, p e722 (2021)
Supplemental Digital Content is available in the text.
Background. Immunosuppression with calcineurin inhibitors (CNIs) is reportedly associated with risk of renal impairment in liver transplant recipients. It is believed that this can be mitiga
Background. Immunosuppression with calcineurin inhibitors (CNIs) is reportedly associated with risk of renal impairment in liver transplant recipients. It is believed that this can be mitiga
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::505134117b685e0c25079134b6713d79
http://hdl.handle.net/10138/334979
http://hdl.handle.net/10138/334979
Publikováno v:
Transplantation. 104:S612-S612
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4f4230dfe85573228709670b485ae697
https://doi.org/10.1097/01.tp.0000701880.37148.c2
https://doi.org/10.1097/01.tp.0000701880.37148.c2
Publikováno v:
Transplantation. 104:S609-S609
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3e76392f14370181fefdd4793beb2552
https://doi.org/10.1097/01.tp.0000701868.30231.bf
https://doi.org/10.1097/01.tp.0000701868.30231.bf